Noninflammatory disorders of female genital tract. Complication associated with artificial fertilization, unspecified
Conditions
Interventions
Intervention 1: Intervention group: Myoinositol 4 gr and Folic Acid 400 microgram was administered one month before the cycle and ovarian stimulation with antagonist protocol will be started on day 2
Sponsors
Vice Chancellor for research of Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
No minimum to 45 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Age below 45 years Body mass index (BMI) between 20-30 low ovarian reserve [both ovarian AFC below 7 or AMH below 1.1 ng/ml or low ovarian response in previous cycle (below 3 oocyte) none history of allergy to Myo-inositol
Exclusion criteria
Exclusion criteria: unwillingness to continue
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of metaphase II oocyte. Timepoint: Time of oocyte pick up. Method of measurement: According to embryolog criteria.;Chemical pregnancy. Timepoint: 2 weeks after embryo transfer. Method of measurement: Serum ßHcG test. | — |
Secondary
| Measure | Time frame |
|---|---|
| Clinical pregnancy. Timepoint: 4 weeks after embryo transfer. Method of measurement: Transvaginal ultrasound.;Ongoing pregnancy. Timepoint: 10 weeks after embryo transfer. Method of measurement: Vision fetal heart beat in ultrasound. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactLeila Nazari
Shahid Beheshti University of Medical Sciences
Outcome results
None listed